Skip to search formSkip to main contentSkip to account menu

JAK2 Gene Mutation

Known as: JAK2 Gene Variant, Janus Kinase 2 (A Protein Tyrosine Kinase) Gene Variant, JAK2 Mutation 
Mutation of the Janus 2 kinase gene at chromosome 9. It is seen in most patients with polycythemia vera and less frequently in other… 
National Institutes of Health

Related topics

Related topics

11 relations
JAK2 NP_004963.1:p.V617FJAK2 NP_004963.1:p.V617XJAK2 NP_004963.1:p.Y931CJAK2 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Different CALR mutation subtypes in essential thrombocythemia and primary myelofibrosis patients without JAK2 mutation
Background Discovery of calreticulin (CALR) mutations are considered essential in understanding the molecular basis of… 
2017
2017
Predictive factors of thrombosis for patients with essential thrombocythaemia: A single center study.
BACKGROUND Thrombotembolic complications are the leading cause of mortality in essential thrombocythemia (ET), but the definition… 
2015
2015
Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.
BACKGROUND AND OBJECTIVES Detection of chromosomal abnormalities in myeloproliferative disorders is important for proper… 
2014
2014
[Recurrent deep vein thrombosis and myeloproliferative syndrom: emergence of JAK2 mutation five years after the initial event].
2014
2014
Mutational spectrum defines primary and secondary myelofibrosis
Essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF) belong to the group of Philadelphia… 
2013
2013
Concomitant JAK2 V617F‐positive polycythemia vera and B‐cell chronic lymphocytic leukemia in three patients originating from two separate hematopoietic stem cells
Rare concurrent PV and CLL patients have been reported(6–8). In these patients, the JAK2 V617F mutation, a marker of PV, was… 
2012
2012
[Biological characteristics of bone marrow mesenchymal stem cells and JAK2 mutation in myeloproliferative neoplasms].
OBJECTIVE To study the biological characteristics of bone marrow mesenchymal stem cells (BMSCs) and detect JAK2 mutation in BMSCs… 
2010
2010
[Correlative study between JAK2 mutation and thrombosis in patients with myeloproliferative neoplasm].
OBJECTIVE To investigate the frequency and clinical implication of JAK2 mutation in patients with myeloproliferative neoplasm(MPN… 
2006
2006
New Detection Method of V617F JAK2 Mutation; Its Use in a Clinical Setting.
Background: A single point mutation in the Janus 2 tyrosine kinase gene leading to a V617F substitution has been described in a… 
2006
2006
Correlation of JAK2 V617F Mutation Status and Cytogenetic Findings in Myeloproliferative Disorders.
Detection of JAK2 V617F mutation is quickly becoming a front-line screening test for suspected myeloproliferative disorders (MPDs… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)